Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    McCune-Albright syndrome, NIH
Show Display Options
Rank Status Study
1 Completed Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention: Drug: Fosamax (Alendronate)
2 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
3 Completed Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
4 Recruiting Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
5 Completed A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia
Intervention: Drug: Pegvisomant
6 Completed Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:

Indicates status has not been verified in more than two years